#340 Crying babies: Can proton pump inhibitors help?
CLINICAL QUESTION
In infants (≤1year) with crying/irritability attributed to feeds, do proton pump inhibitors (PPIs) improve symptoms over placebo without additional harms?
BOTTOM LINE
PPIs do not improve crying, fussiness, irritability, or regurgitation attributed to feeds. However, PPIs may increase the risk of serious adverse effects (e.g., respiratory tract infections) from 2.5% on placebo to 12% at 4 weeks.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
- Results statistically significant unless indicated. Randomized, controlled trials (RCTs) on infants retrieved from systematic reviews in the last ten years since no meta-analyses available.1-5
- Two placebo-controlled RCTs of PPIs; four-week duration:6,7
- 162 infants (median age: 4 months) crying within 1 hour of ≥25% of feeds; lansoprazole (0.2-1.5mg/kg/day):6
- ≥50% reduction in feedings with crying episode(s)/duration of episodes: 54% in each group.
- Crying, regurgitations, stopped feedings, feed refusal, back arching: No differences.
- Serious adverse events (e.g., respiratory tract infections): 12% versus 2.5% (placebo), number needed to harm (NNH)=10.
- 30 infants (mean age: 5 months) with frequent crying and reflux confirmed on biopsy/pH monitoring; omeprazole (10-20mg/day):7
- Crying/fussing (minutes/24 hours): No difference.
- Irritability (0-10 visual analogue score, lower=better): No difference.
- 162 infants (median age: 4 months) crying within 1 hour of ≥25% of feeds; lansoprazole (0.2-1.5mg/kg/day):6
- No placebo-controlled RCTs of histamine-2 receptor antagonists.
- Head-to-head comparisons versus PPI: No difference.8
- Four withdrawal RCTs (8-268 infants, 1-11 months): Open-label treatment with rabeprazole,9 esomeprazole,10 pantoprazole,11 or famotidine12 x 1-4 weeks; responders/compliers randomized to blinded continued drug or placebo. At 4-5 weeks:
- Vomiting, regurgitation, irritability, feeding difficulties, symptoms scores, adverse effects: No differences.9-11
- Weight: No difference.9
- Limitations: Most RCTs industry funded.6,9-12
CONTEXT
- Frequent effortless regurgitation of feeds is common in early infancy (affecting ≥40%).13
- Regurgitation accompanied by distress symptoms (e.g., crying, back arching, irritability) have traditionally been attributed to gastroesophageal reflux disease. While PPIs improve esophageal pH in infant RCTs,7 they do not improve symptoms.
- Guidelines recommend against empiric trials of acid-suppressing drugs for crying/distress or regurgitation.13,14 Parents can be reassured that frequent regurgitation can be normal and frequently settles (90% have resolution at age ≤1 year).13
Latest Tools for Practice
#379 Bumpin’ Up the Protection? RSV Vaccine in Pregnancy
How effective and safe is the respiratory syncytial virus (RSV) vaccine (AbrysvoTM) when given during pregnancy?
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
no benefit to PPI’s
reinforces regurg very common and PPI actually harm
Frequent regurgitation is common in infancy